Two hundred thousand Americans, and only one psychedelic stood out
What they did
Researchers analysed responses from 214,505 US adults in national survey data from 2015 to 2019, testing whether lifetime use of each classic psychedelic tracked with opioid use disorder.
What they found
Psilocybin was the only substance associated with lower odds of past-year opioid use disorder, at roughly 30 percent lower odds. Peyote, mescaline and LSD showed no comparable association.
Worth knowing
Cross-sectional survey data showing an association, not a trial and not causal. People who have used psilocybin differ from those who have not in ways no survey adjustment fully removes. It does replicate an earlier finding, which is worth something.
Jones et al. Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample. Scientific Reports, 2022.
Read the sourceKeep reading
smokingPsilocybin beat the nicotine patch four to onecocainePsilocybin reduced cocaine use in its first controlled trialalcoholHeavy drinking days cut by more than halfA lot of our customers arrive from the sober curious side rather than the psychedelic side. If that is you, the alcohol research below is the most relevant on the whole shelf. See what we make.
For education, not medical advice. Every write-up links back to the original source.
Nothing here is a claim that our products treat, cure or prevent any condition. Talk to a doctor before changing anything about your health.